Levetiracetam Wockhardt (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. By stabilising neuronal membranes and decreasing abnormal neuronal firing, it lowers overall brain excitability and reduces the likelihood of seizure generation.

The appropriate dose of Levetiracetam Wockhardt is determined by the prescribing healthcare professional based on the patient’s age, weight, renal function, and seizure type. Dosage regimens are individualized and should follow the prescriber’s instructions.

Safety data for levetiracetam in pregnancy and lactation are limited. The potential benefits and risks should be carefully evaluated by the prescriber. Women who are pregnant, planning pregnancy, or breastfeeding should discuss treatment options with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Levetiracetam offers a distinct mechanism by targeting SV2A, which differs from sodium‑channel blockers like carbamazepine or GABA‑enhancing agents such as valproate. It is generally well‑tolerated, has fewer drug‑enzyme interactions, and can be used as monotherapy or adjunct therapy across multiple seizure types.

Levetiracetam Wockhardt should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and excessive heat to maintain its stability and potency.

Levetiracetam Wockhardt is taken orally, usually as a tablet. It can be swallowed whole with water, and may be taken with or without food. The exact administration schedule should follow the prescriber’s directions.

Serious risks include severe allergic reactions such as anaphylaxis, skin conditions like Stevens‑Johnson syndrome, and neuropsychiatric events such as suicidal thoughts or severe depression. Patients should seek immediate medical attention if they experience any of these symptoms.

Levetiracetam is contraindicated in individuals with known hypersensitivity to levetiracetam or any of its excipients. Patients with severe renal impairment may require dose adjustments, and those with uncontrolled psychiatric conditions should be evaluated carefully before use.